Old approval and care today | Sermorelin specialist guide

The short answer

The U.S. agency for medicine reviews has the full name Food and Drug Administration; these briefings use its initials, FDA.

As of September 2026, there is no marketed FDA-approved sermorelin product in the U.S.

Sermorelin (Geref) had FDA approval in the past; that does not approve a pharmacy's medicine today.

Keep these distinctions clear

What the old medicine was for
The U.S. approval record was checked in September 2026.
1. The FDA approved sermorelin (Geref) in December 1990 for a test of whether the body could release growth hormone, a chemical message made by the body.
2. In September 1997, approval followed for children with low growth hormone whose growth was falling short.
3. After the maker requested withdrawal from the FDA, both approvals came to an end on June 18, 2009.
Those uses did not include adult energy, sleep, body shape, or ageing.
When pharmacy-made care may be lawful
A state-licensed pharmacy may prepare sermorelin acetate when a valid prescription names the patient, provided the pharmacy meets the other federal and state rules; this describes the position as of September 2026.
Sermorelin acetate is the specific version of the ingredient used in Geref, the old medicine.
Permission to use that ingredient does not cover every version of sermorelin.
An FDA-registered maker must supply the raw ingredient, which also needs a certificate of analysis documenting its test results.
If an official standard for the ingredient's quality applies, the ingredient must meet it.
Federal rules also restrict regular copying of medicines already on sale; Geref is no longer sold.
State pharmacy rules can add limits.
- Where does the ingredient come from, and what testing paperwork comes with it?
- Which quality standards for the ingredient and state rules apply to my medicine?
The FDA documents used here support possible lawful pharmacy use, but none gives an ordinary pharmacy permission for sermorelin by name.
These are key checks, not a full legal checklist or a finding that a particular pharmacy meets the rules.
Ask the pharmacist to explain how the medicine offered to you meets the rules before agreeing to care.
What compounding does not prove
A medicine prepared to order by a doctor or pharmacy is described as compounded.
For compounded medicines, safety, quality, and benefit receive no FDA review before sale, as of September 2026.
If a service calls its compounded sermorelin FDA-approved, ask it to correct that claim.

Ask the doctor and pharmacist

Is my prescription for sermorelin acetate? Which pharmacy will make it? Which ingredient checks and state rules does this medicine meet?

Keep a question

Keep the wording you want explained at the assessment.

This box saves text only in this browser. Each briefing keeps its own notes.

Questions to keep

To save here, enable JavaScript. Otherwise, copy your question before leaving.

Brief source notes

The FDA's Geref history notice
The notice records the old uses and the later withdrawal history.
FDA rules for ingredients used by ordinary pharmacies
Ask the pharmacist where the ingredient comes from, what testing paperwork comes with it, and which state rules apply.
FDA explanation of compounded medicines
This explains what compounding does and how its review differs from a finished approved medicine.

Next briefing: Evidence